BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 28039484)

  • 1. Vascular endothelial growth factor gene polymorphisms and the risk of renal cell carcinoma: Evidence from eight case-control studies.
    Gong M; Dong W; Shi Z; Qiu S; Yuan R
    Oncotarget; 2017 Jan; 8(5):8447-8458. PubMed ID: 28039484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between SNPs in vascular endothelial growth factor polymorphisms and risk of renal cell carcinoma: a case-control study.
    Shen BL; Qu QS; Miao SZ; Zhang YX
    Genet Mol Res; 2015 Sep; 14(3):11119-25. PubMed ID: 26400342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas.
    Xian W; Zheng H; Wu WJ
    Genet Mol Res; 2015 Jul; 14(3):7634-42. PubMed ID: 26214443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between vascular endothelial growth factor gene polymorphisms and the risk and prognosis of renal cell carcinoma: A systematic review and meta-analysis.
    Tang J; Qin Z; Li X; Han P; Wang F; Yang C; Li R; Wang K; Tang M; Wang W; Lv Q; Zhang W
    Oncotarget; 2017 Jul; 8(30):50034-50050. PubMed ID: 28489583
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictive value of vascular endothelial growth factor polymorphisms on the risk of renal cell carcinomas: a case-control study.
    Lu G; Dong Y; Zhang Q; Jiao L; Yang S; Shen B
    Tumour Biol; 2015 Nov; 36(11):8645-52. PubMed ID: 26044558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. VEGF polymorphisms are not associated with an increased risk of developing renal cell carcinoma in Spanish population.
    Sáenz-López P; Vazquez F; Cozar JM; Carretero R; Garrido F; Ruiz-Cabello F
    Hum Immunol; 2013 Jan; 74(1):98-103. PubMed ID: 23073296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular endothelial growth factor gene polymorphisms and gastric cancer risk: a meta-analysis.
    Zhuang M; Peng Z; Wang J; Su X
    J BUON; 2017; 22(3):714-724. PubMed ID: 28730780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint Effect of Urinary Total Arsenic Level and VEGF-A Genetic Polymorphisms on the Recurrence of Renal Cell Carcinoma.
    Yang SM; Huang CY; Shiue HS; Huang SP; Pu YS; Chen WJ; Lin YC; Hsueh YM
    PLoS One; 2015; 10(12):e0145410. PubMed ID: 26701102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular endothelial growth factor (VEGF) gene polymorphisms and colorectal cancer: a meta-analysis of epidemiologic studies.
    Zhao Z; Ba C; Wang W; Wang X; Xue R; Wu X
    Genet Test Mol Biomarkers; 2012 Dec; 16(12):1390-4. PubMed ID: 23005896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of a single-nucleotide polymorphism in the promoter region of the VEGF gene with the risk of renal cell carcinoma.
    Ajaz S; Khaliq S; Abid A; Hassan AS; Hashmi A; Sultan G; Mohsin R; Mubarrak M; Naqvi SA; Rizvi SA; Mehdi SQ
    Genet Test Mol Biomarkers; 2011 Sep; 15(9):653-7. PubMed ID: 21491998
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of vascular endothelial growth factor polymorphisms with clinical outcome of renal cell carcinoma patients.
    Zhong W; Wang X; Pan B; Su Z
    Tumour Biol; 2014 Oct; 35(10):9839-45. PubMed ID: 24989926
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Five polymorphisms of vascular endothelial growth factor (VEGF) and risk of breast cancer: a meta-analysis involving 16,703 individuals.
    Wang K; Liu L; Zhu ZM; Shao JH; Xin L
    Cytokine; 2011 Nov; 56(2):167-73. PubMed ID: 21798757
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined effect of vascular endothelial growth factor and its receptor polymorphisms in endometriosis: a case-control study.
    Cardoso JV; Abrão MS; Vianna-Jorge R; Ferrari R; Berardo PT; Machado DE; Perini JA
    Eur J Obstet Gynecol Reprod Biol; 2017 Feb; 209():25-33. PubMed ID: 27836223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between three VEGF polymorphisms and renal cell carcinoma susceptibility: a meta-analysis.
    Hou Q; Li MY; Huang WT; Wei FF; Peng JP; Lou MW; Qiu JG
    Oncotarget; 2017 Jul; 8(30):50061-50070. PubMed ID: 28562357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor +405G/C and -2578C/A polymorphisms and breast cancer risk: a meta-analysis.
    Zhang Y; Yu YF; Wang JZ; Jia H
    Genet Mol Res; 2015 Aug; 14(3):8909-18. PubMed ID: 26345822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Associations of single nucleotide polymorphisms in the vascular endothelial growth factor gene with the characteristics and prognosis of renal cell carcinomas.
    Kawai Y; Sakano S; Korenaga Y; Eguchi S; Naito K
    Eur Urol; 2007 Oct; 52(4):1147-55. PubMed ID: 17287073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation on association between five common polymorphisms in vascular endothelial growth factor and prototypes of autoimmune diseases.
    Che N; Li Y; Liu S; Pan W; Liu Y
    Immunobiology; 2015 Jun; 220(6):722-33. PubMed ID: 25641412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Vascular Endothelial Growth Factor Gene Polymorphisms and Pre-Eclampsia Susceptibility: An Updated Meta-Analysis.
    Wang X; Sun T; Chen G; Gao H
    Immunol Invest; 2020 Feb; 49(1-2):120-133. PubMed ID: 31455120
    [No Abstract]   [Full Text] [Related]  

  • 19. Vascular endothelial growth factor gene polymorphisms and colorectal cancer risk: a meta-analysis.
    Zhou LP; Luan H; Dong XH; Jin GJ; Man DL; Shang H
    Genet Mol Res; 2011 Oct; 10(4):3674-88. PubMed ID: 22058001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vascular endothelial growth factor +936C/T, -634G/C, -2578C/A, and -1154G/A polymorphisms with risk of preeclampsia: a meta-analysis.
    Cheng D; Hao Y; Zhou W; Ma Y
    PLoS One; 2013; 8(11):e78173. PubMed ID: 24223772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.